133 related articles for article (PubMed ID: 28168814)
1. Targeting multiple pathways reduces renal and cardiac fibrosis in rats with subtotal nephrectomy followed by coronary ligation.
Oosterhuis NR; Bongartz LG; Verhaar MC; Cheng C; Xu YJ; van Koppen A; Cramer MJ; Goldschmeding R; Gaillard CA; Doevendans PA; Braam B; Joles JA
Acta Physiol (Oxf); 2017 Jul; 220(3):382-393. PubMed ID: 28168814
[TBL] [Abstract][Full Text] [Related]
2. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
[TBL] [Abstract][Full Text] [Related]
3. Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy.
Karanovic D; Grujic-Milanovic J; Miloradovic Z; Ivanov M; Jovovic D; Vajic UJ; Zivotic M; Markovic-Lipkovski J; Mihailovic-Stanojevic N
PLoS One; 2016; 11(8):e0161706. PubMed ID: 27560781
[TBL] [Abstract][Full Text] [Related]
4. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice.
Ding W; Wang B; Zhang M; Gu Y
Cell Physiol Biochem; 2015; 36(6):2170-82. PubMed ID: 26279424
[TBL] [Abstract][Full Text] [Related]
5. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension.
Dobrian AD; Schriver SD; Prewitt RL
Hypertension; 2001 Sep; 38(3):361-6. PubMed ID: 11566905
[TBL] [Abstract][Full Text] [Related]
6. Chronic NF-κB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats.
Luo H; Wang X; Wang J; Chen C; Wang N; Xu Z; Chen S; Zeng C
Cardiovasc Diabetol; 2015 Jun; 14():76. PubMed ID: 26055622
[TBL] [Abstract][Full Text] [Related]
7. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats.
Elmedal B; de Dam MY; Mulvany MJ; Simonsen U
Br J Pharmacol; 2004 Jan; 141(1):105-13. PubMed ID: 14656807
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic antioxidant therapy with superoxide dismutase-mimetic drug, tempol, on progression of renal disease in rats with renal mass reduction.
Quiroz Y; Ferrebuz A; Vaziri ND; Rodriguez-Iturbe B
Nephron Exp Nephrol; 2009; 112(1):e31-42. PubMed ID: 19342872
[TBL] [Abstract][Full Text] [Related]
9. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
Bayorh MA; Mann G; Walton M; Eatman D
Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of angiotensin II and the NF-κB system in a model of malignant hypertensive nephrosclerosis.
Ávila VF; Foresto-Neto O; Arias SCA; Faustino VD; Malheiros DMAC; Camara NOS; Zatz R; Fujihara CK
Hypertens Res; 2019 Jun; 42(6):779-789. PubMed ID: 30809002
[TBL] [Abstract][Full Text] [Related]
11. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
Iglarz M; Touyz RM; Viel EC; Amiri F; Schiffrin EL
Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
Álvarez-Prats A; Hernández-Perera O; Díaz-Herrera P; Ucero ÁC; Anabitarte-Prieto A; Losada-Cabrera A; Ortiz A; Rodríguez-Pérez JC
Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
Miloradović Z; Jovović D; Mihailović-Stanojević N; Milanović JG; Milanović S
Can J Physiol Pharmacol; 2008 Apr; 86(4):210-4. PubMed ID: 18418431
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease.
Xu C; Ding W; Zhang M; Gu Y
Nephrology (Carlton); 2013 Dec; 18(12):761-9. PubMed ID: 23901805
[TBL] [Abstract][Full Text] [Related]
16. Post-Natal Inhibition of NF-κB Activation Prevents Renal Damage Caused by Prenatal LPS Exposure.
Guo W; Guan X; Pan X; Sun X; Wang F; Ji Y; Huang P; Deng Y; Zhang Q; Han Q; Yi P; Namaka M; Liu Y; Deng Y; Li X
PLoS One; 2016; 11(4):e0153434. PubMed ID: 27073902
[TBL] [Abstract][Full Text] [Related]
17. Perinatal inhibition of NF-kappaB has long-term antihypertensive effects in spontaneously hypertensive rats.
Koeners MP; Braam B; Joles JA
J Hypertens; 2011 Jun; 29(6):1160-6. PubMed ID: 21505356
[TBL] [Abstract][Full Text] [Related]
18. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
19. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
[TBL] [Abstract][Full Text] [Related]
20. Superoxide dismutase mimetic, tempol, aggravates renal injury in advanced-stage stroke-prone spontaneously hypertensive rats.
Sugama I; Kohagura K; Yamazato M; Nakamura T; Shinzato T; Ohya Y
J Hypertens; 2014 Mar; 32(3):534-41. PubMed ID: 24309490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
